This bibliometric analysis provides valuable insights into the global research landscape of BRAF and MEK inhibitor resistance in melanoma, offering a comprehensive understanding of key contributors, research trends, and emerging therapeutic strategies. The gene discussed is BRAF; the disease is melanoma.